Infliximab for the treatment of refractory scleritis. - Wikidata - wikimedia - TriplyDB

Infliximab for the treatment of refractory scleritis.

Infliximab for the treatment of refractory scleritis.

http://www.wikidata.org/entity/Q42375263

about

Systemic adalimumab induces peripheral corneal infiltrates: a case report.Combined infliximab and rituximab in necrotising scleritis Pharmacotherapy of scleritis: current paradigms and future directions.Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS)-report 4: analysis and outcome of scleritis in an East Asian population.TNF inhibition for ophthalmic indications: current status and outlook.Ocular inflammatory diseases associated with rheumatoid arthritis.Infliximab for peripheral ulcerative keratitis treatment.Biologic therapy for refractory scleritis: a new treatment perspective.Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects.Use of biologic agents in ocular manifestations of rheumatic disease.Episcleritis Related to Drug-Induced Lupus Erythematosus following Infliximab Therapy: A Case Report.Use of hydroxychloroquine in corticodependent and recurrent scleritis.Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease.Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study

P2860

Q35686285-88353399-68E6-41B1-AEC6-C0CB5BEDC68D Q36488549-02BD789A-30AA-4FD0-B747-764C38FA6BAF Q37466204-C449885F-9C7E-41E8-83A3-3EDD30B52BAA Q37643844-3E88A451-0732-4414-96D4-9BB55A076784 Q38097327-D62D2551-55A8-4FF7-9004-39224784720E Q38169978-DCC66692-F183-452A-8D21-C0B3081A6952 Q38283034-7104DA54-9002-47A4-A0A1-E38BDB96D96A Q38576234-C1C6E79D-7BA4-4C09-A0CD-FEFA4F6FF0ED Q38801020-E2E30425-737D-4B04-9894-4C5BA9423DFD Q40008319-4505A38C-5014-4A4C-8EBF-4A7E32129E07 Q41871391-8620B53F-9B2C-487E-AA33-051495DC2B3A Q46056869-D72F2AC3-420B-4129-AA46-0CC77A55043B Q50075113-A5892AD2-AAE4-4117-9430-6127BDE27DA9 Q58621562-FEFE3BDB-11A3-4359-8DD2-82820DC5F7FD

P2860

Infliximab for the treatment of refractory scleritis.

http://www.wikidata.org/entity/Q42375263

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Infliximab for the treatment of refractory scleritis.

@en

Infliximab for the treatment of refractory scleritis.

@nl

type

label

Infliximab for the treatment of refractory scleritis.

@en

Infliximab for the treatment of refractory scleritis.

@nl

prefLabel

Infliximab for the treatment of refractory scleritis.

@en

Infliximab for the treatment of refractory scleritis.

@nl

P1433

Q42375263-D006FF16-CC77-4316-B8D7-70E88C8781D8

P1476

Q42375263-54017893-108A-429E-BA7F-ACD7D2EE37E0

P2093

Q42375263-0C43F6F6-E3DC-437E-A310-D70886DF921F

Q42375263-11B23D11-609E-41A7-B962-CC1CB1DCBC35

Q42375263-A7BE64F9-DED3-4C14-B5A7-B307B0CBFDA3

Q42375263-B19E5DDD-7AD4-45D8-AED9-CBD65844CAD9

Q42375263-E257D150-7865-477A-9384-3EB9A9AD7810

P2860

Q42375263-07B161B9-7BE2-4E67-A741-48872EBDE1D9

Q42375263-37EC7AF4-20A7-49E2-BFDE-C241D2669FB3

Q42375263-396EBBCF-BBA9-48E2-802A-A03D27C8EB44

Q42375263-5A273661-9812-4D9D-B5A7-E6184353ED59

Q42375263-5EB61A04-765C-488B-A9A5-D5846796505C

Q42375263-6C002065-C86D-422E-B704-8BE17E6B9E6B

Q42375263-6D7BA395-D527-4BB2-B9EC-D57674470520

Q42375263-994F7C90-8E2C-4763-AA6A-ADFA6509B7AF

Q42375263-ACFD1025-6830-4EB5-A792-1C542B738114

Q42375263-E447106E-FABA-47CD-B40C-B9AFE153285B

P304

Q42375263-C9E5B23C-8608-4AF5-80B5-4005188C59B0

P31

Q42375263-1E4E05BB-548C-4931-B4AB-218C836E373B

P356

Q42375263-043ABEAD-B2C9-4142-9D79-BE9D51DD4EB8

P407

Q42375263-9F77FC10-030E-4DCD-AB83-3847232B1AB5

P433

Q42375263-16229B82-7183-49C5-A5DF-6F97AF77590E

P478

Q42375263-ED6CE6CA-0B4B-4F52-BE59-14B1F26AEDF0

P50

Q42375263-628CEBF2-A485-4871-847F-1B50AA465283

P577

Q42375263-AC497AF3-103D-4A10-A8AD-DBEE97DD0F79

P5875

Q42375263-01CC6ACA-49EF-41B3-85A3-A125B296A4DC

P698

Q42375263-E94903FB-5A00-4CE3-B953-01786BDBC05A

P932

Q42375263-05C0919E-FBDB-4596-9C5D-E2307A336995

P356

BJO.2008.150961

P1433

British Journal of Ophthalmology

P1476

Infliximab for the treatment of refractory scleritis.

@en

P2093

Amyna Sultan

http://www.w3.org/2001/XMLSchema#string

C Stephen Foster

http://www.w3.org/2001/XMLSchema#string

Pooja Bhat

http://www.w3.org/2001/XMLSchema#string

Priyanka Doctor

http://www.w3.org/2001/XMLSchema#string

William Christen

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

Scleritis and episcleritis.

Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use.

Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation.

Current state of biologicals in the management of systemic vasculitis.

Biological and clinical effects of anti-TNFalpha treatment.

Drug-induced lupus due to anti-tumor necrosis factor alpha agents.

Infliximab (Remicade) in the treatment of psoriatic arthritis.

Posterior scleritis.

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

P304

579-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.2008.150961

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40442347

http://www.w3.org/2001/XMLSchema#string

P698

19955205

http://www.w3.org/2001/XMLSchema#string

P932

2976470

http://www.w3.org/2001/XMLSchema#string